Search results
FUJIFILM's (FUJIY) Q4 Earnings and Revenues Increase Y/Y
Zacks via Yahoo Finance· 4 days agoFUJIFILM's (FUJIY) fiscal fourth-quarter performance is driven by healthy revenue growth in the...
Earnings call: 2seventy bio eyes growth with focus on Abecma in Q1 2024 By Investing.com
Investing.com· 3 days ago2seventy bio (Ticker: TSVB) reported its financial results and business updates during its First...
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 2 days agoInvestors and stakeholders can look forward to Zura Bio's continued progress in its innovative therapeutic programs, which are designed to offer new hope to patients with ...
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic De
Guru Focus· 2 days agoZura Bio Ltd (ZURA, Financial), a pioneering clinical-stage biotechnology firm specializing in novel treatments for immune and inflammatory disorders, disclosed its financial ...
bluebird bio reports first commercial gene therapy use By Investing.com
Investing.com· 6 days agoThis development marks a major step in making the treatment accessible to patients with a history of...
Recognize National Women's Health Week by Taking Care of Your Gut Microbiome With Gundry MD Total...
FOX 23 News Albany· 14 hours agoNational Women's Health Week encourages women to prioritize their well-being through preventive...
Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results A
Guru Focus· 5 days agoOn May 7, 2024, Bio-Rad Laboratories Inc (BIO, Financial) released its 8-K filing, disclosing its financial results for the first quarter ended March 31 ...
TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses
Guru Focus· 2 days agoTELA Bio Inc (TELA, Financial), a prominent player in the medical technology industry, specializing in soft tissue reconstruction, disclosed its financial outcomes for the ...
CryoPort Inc (CYRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 5 days agoWe expect a strong second half ramp-up based on new therapy approvals and increased biotech funding. We also anticipate new revenue from products and services launched throughout the year. For ...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlight
Guru Focus· 6 days agoAsset Sale: Agreement to sell Bio-Reference health assets to LabCorp for $237.5 million.Revenue: Q1 2024 revenue for Diagnostics segment reported at $126.9 mil